ISSCR News
Stem Cell Reports Seeks Early Career Editors to Join the Editorial Board
Stem Cell Reports, the peer-reviewed, open-access journal of the International Society for Stem Cell Research (ISSCR), today announced a call for applications to serve on its editorial team, a prestigious opportunity for outstanding, early-career scientists to help shape the future of stem cell publishing. The deadline to apply is 13 March 2026.
Selected members will serve up to a three-year term beginning 1 September 2026, joining a cohort of distinguished early career researchers who will play an active role in the journal’s scientific vision and community engagement. The program is designed to provide hands-on editorial experience, mentorship, and professional visibility within the global stem cell research community.
Member Spotlight: Xiaokui Zhang, PhD
ISSCR provides an unparalleled global community and evolving standards that bring together scientific excellence, ethical leadership, and collaboration. I value the society’s role in educating patients and convening international dialogue at conferences and symposiums.
Stem Cell Reports Most Downloaded Papers of 2025 Highlight the Breadth and Impact of Stem Cell Research
The International Society for Stem Cell Research (ISSCR) today announced the 10 most downloaded papers of 2025 from Stem Cell Reports, its peer-reviewed, open-access journal. Together, these highly read articles reflect the extraordinary scientific range of the field – from foundational mechanisms of pluripotency and differentiation to translational advances in regenerative medicine, disease modeling, and bioethics – and underscore the journal’s role as a trusted platform for impactful stem cell science.
The ISSCR Joins Coalition Letter in Support of ARPA-H Funding
The ISSCR joined over 100 biomedical research organizations and institutions to urge congressional appropriators to provide at least $1.5 billion for the Advanced Research Projects Agency for Health (ARPA-H). ARPA-H supports high-risk, high-reward biomedical research projects and was established in 2022 to complement the role of the National Institutes of Health. This investment would enable ARPA-H to continue supporting stem cell research and regenerative medicine projects aimed at advancing stem cell research and accelerating clinical breakthroughs.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .